FDG-PET/CT在感染与炎症中的局限性与陷阱
本文综述FDG-PET/CT诊断感染与炎症性疾病时的局限性和潜在陷阱,涵盖头颈、心血管、腹部器官和肌肉骨骼系统最常见疾病。感染或炎症的FDG摄取较肿瘤更弥漫且缺乏特征性,受累器官常有生理性摄取,且患者检查时多已接受抗生素、皮质类固醇或免疫调节药物,导致假阳性率较高、部分病例敏感性降低。文中还简要介绍了可能克服这些局限的PET/CT新进展。
要点
- 感染/炎症FDG摄取较肿瘤更弥漫且缺乏特征性,受累器官常有生理性摄取。
- 患者检查时多已接受抗生素、皮质类固醇或免疫调节药物,影响结果判读。
- 上述因素共同导致假阳性率较高,部分病例检测活动性疾病的敏感性降低。
核心结论
- FDG-PET/CT用于感染与炎症性疾病诊断时存在局限性和潜在陷阱,假阳性率较高,部分病例敏感性降低。
研究设计与样本
- 本文为综述,讨论FDG-PET/CT诊断感染与炎症的局限性与陷阱,涵盖头颈、心血管、腹部器官和肌肉骨骼系统最常见疾病,并简要介绍PET/CT新进展。
主要发现
- 感染或炎症的FDG摄取较肿瘤FDG PET/CT更弥漫且缺乏特征性,受累器官通常有生理性FDG摄取。
- 转诊疑似感染或炎症的患者检查时很少未接受治疗,可能已接受不同剂量的抗生素、皮质类固醇或其他免疫调节药物。
- 上述因素共同导致FDG假阳性发现率较高,部分病例检测活动性疾病的敏感性降低。
- 部分局限性为一般性,与急重症患者PET图像采集费力有关;另一些为疾病特异性,与常见感染或炎症器官的特定代谢有关。
临床怎么用
- 判读感染与炎症FDG-PET/CT时需考虑受累器官生理性摄取、病变摄取弥漫缺乏特征性及治疗药物影响,警惕假阳性。
局限性
- 原文为综述,未报告具体样本量、阈值、剂量或统计学指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
White blood cells activated by either a pathogen or as part of a systemic inflammatory disease are characterized by high energy consumption and are therefore taking up the glucose analogue PET tracer FDG avidly. It is therefore not surprising that a steadily growing body of research and clinical reports now supports the use of FDG PET/CT to diagnose a wide range of patients with non-oncological diseases. However, using FDG PET/CT in patients with infectious or inflammatory diseases has some limitations and potential pitfalls that are not necessarily as pronounced in oncology FDG PET/CT. Some of these limitations are of a general nature and related to the laborious acquisition of PET images in patients that are often acutely ill, whereas others are more disease-specific and related to the particular metabolism in some of the organs most commonly affected by infections or inflammatory disease. Both inflammatory and infectious diseases are characterized by a more diffuse and less pathognomonic pattern of FDG uptake than oncology FDG PET/CT and the affected organs also typically have some physiological FDG uptake. In addition, patients referred to PET/CT with suspected infection or inflammation are rarely treatment naïve and may have received varying doses of antibiotics, corticosteroids or other immune-modulating drugs at the time of their examination. Combined, this results in a higher rate of false positive FDG findings and also in some cases a lower sensitivity to detect active disease. In this review, we therefore discuss the limitations and pitfalls of FDG PET/CT to diagnose infections and inflammation taking these issues into consideration. Our review encompasses the most commonly encountered inflammatory and infectious diseases in head and neck, in the cardiovascular system, in the abdominal organs and in the musculoskeletal system. Finally, new developments in the field of PET/CT that may help overcome some of these limitations are briefly highlighted.
引用
- Pijl JP, Nienhuis PH, Kwee TC, et al. Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation. Semin Nucl Med. 2021. PMID: 34246448. doi:10.1053/j.semnuclmed.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。